Freud's Last Session Goes International Dec. 9, Opening in Sweden | Playbill

Related Articles
News Freud's Last Session Goes International Dec. 9, Opening in Sweden The long-running Off-Broadway play Freud's Last Session opens in its first foreign production Dec. 9 at Sweden's Stockholm City Theatre. The limited engagement continues through Dec. 20.

Directed by Stina Rautelin, the production stars Tomas Bolme as Sigmund Freud and Ole Forsberg as C. S. Lewis.

Mark St. Germain's drama about the fictional meeting between Christian writer C.S. Lewis and atheist psychoanalyst Sigmund Freud — in his London study — opened July 22, 2010, at the Marjorie S. Deane Little Theatre. The production ended its run at the Little Theatre Oct. 2, 2011, and reopened Off-Broadway at New World Stages Oct. 16, 2011.

The current production at New World features Mark H. Dold (as C.S. Lewis) and Martin Rayner (as Sigmund Freud). Freud's Last Session is the winner of the 2011 Off-Broadway Alliance Award for Best Play, and is produced by Carolyn Rossi Copeland, Robert Stillman and Jack Thomas.

Additional productions of Freud's Last Session have happened or are planned for London, Madrid, Buenos Aires, Tokyo, Rio de Janeiro, Los Angeles, Mexico City, Chicago, Seattle, Atlanta, Orlando, Pittsburgh, Detroit and Palm Beach.

Freud's Last Session, according to production notes, "centers on legendary psychoanalyst Dr. Sigmund Freud, who invites the young, rising academic star C. S. Lewis to his home in London. Lewis, expecting to be called on the carpet for satirizing Freud in a recent book, soon realizes Freud has a much more significant agenda." The play, set on the day England enters World War II, has Freud and Lewis clash over "the existence of God, love, sex, and the meaning of life – only two weeks before Freud chooses to take his own."

For more information, visit www.FreudsLastSession.com.

 
RELATED:
Today’s Most Popular News:
 X

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting playbill.com with your ad blocker.
Thank you!